384 related articles for article (PubMed ID: 19932084)
21. Interactions between the apolipoprotein a1/c3/a5 haplotypes and alcohol consumption on serum lipid levels.
Yin RX; Li YY; Wu JZ; Pan SL; Liu CW; Lin WX; Yang DZ
Alcohol Clin Exp Res; 2013 Feb; 37(2):234-43. PubMed ID: 22924697
[TBL] [Abstract][Full Text] [Related]
22. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes.
Qi L; Liu S; Rifai N; Hunter D; Hu FB
Atherosclerosis; 2007 May; 192(1):204-10. PubMed ID: 16781717
[TBL] [Abstract][Full Text] [Related]
23. Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.
Lai CQ; Arnett DK; Corella D; Straka RJ; Tsai MY; Peacock JM; Adiconis X; Parnell LD; Hixson JE; Province MA; Ordovas JM
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1417-25. PubMed ID: 17431185
[TBL] [Abstract][Full Text] [Related]
24. Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.
Smith RC; Segman RH; Golcer-Dubner T; Pavlov V; Lerer B
Pharmacogenomics J; 2008 Jun; 8(3):228-36. PubMed ID: 17726453
[TBL] [Abstract][Full Text] [Related]
25. The APOA5 Trp19 allele is associated with metabolic syndrome via its association with plasma triglycerides.
Dallongeville J; Cottel D; Wagner A; Ducimetière P; Ruidavets JB; Arveiler D; Bingham A; Ferrières J; Amouyel P; Meirhaeghe A
BMC Med Genet; 2008 Sep; 9():84. PubMed ID: 18789138
[TBL] [Abstract][Full Text] [Related]
26. The Relation between Metabolic Syndrome Risk Factors and Genetic Variations of Apolipoprotein V in Relation with Serum Triglyceride and HDL-C Level.
Fallah MS; Sedaghatikhayat B; Guity K; Akbari F; Azizi F; Daneshpour MS
Arch Iran Med; 2016 Jan; 19(1):46-50. PubMed ID: 26702748
[TBL] [Abstract][Full Text] [Related]
27. The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II.
Talmud PJ; Cooper JA; Hattori H; Miller IP; Miller GJ; Humphries SE
Diabetologia; 2006 Oct; 49(10):2337-40. PubMed ID: 16917759
[TBL] [Abstract][Full Text] [Related]
28. Genetic variants of apolipoprotein A5 T-1131C and apolipoprotein E common polymorphisms and their relationship to features of metabolic syndrome in adult dyslipidemic patients.
Novotny D; Vaverkova H; Karasek D; Malina P
Clin Biochem; 2014 Aug; 47(12):1015-21. PubMed ID: 24709297
[TBL] [Abstract][Full Text] [Related]
29. Investigation of associations between apolipoprotein A5 and C3 gene polymorphisms with plasma triglyceride and lipid levels.
Taşkin E; Bağci H; Turan MK
Rev Assoc Med Bras (1992); 2023; 69(3):415-420. PubMed ID: 36921196
[TBL] [Abstract][Full Text] [Related]
30. Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men.
Dallongeville J; Cottel D; Montaye M; Codron V; Amouyel P; Helbecque N
Int J Cardiol; 2006 Jan; 106(2):152-6. PubMed ID: 16321685
[TBL] [Abstract][Full Text] [Related]
31. The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease.
Jang Y; Paik JK; Hyun YJ; Chae JS; Kim JY; Choi JR; Lee SH; Shin DJ; Ordovas JM; Lee JH
Clin Chim Acta; 2009 Apr; 402(1-2):83-7. PubMed ID: 19159622
[TBL] [Abstract][Full Text] [Related]
32. Two independent apolipoprotein A5 haplotypes modulate postprandial lipoprotein metabolism in a healthy Caucasian population.
Moreno-Luna R; Perez-Jimenez F; Marin C; Perez-Martinez P; Gomez P; Jimenez-Gomez Y; Delgado-Lista J; Moreno JA; Tanaka T; Ordovas JM; Lopez-Miranda J
J Clin Endocrinol Metab; 2007 Jun; 92(6):2280-5. PubMed ID: 17356049
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
[TBL] [Abstract][Full Text] [Related]
34. Association between plasma lipid parameters and APOC3 genotypes in Brazilian subjects: effect of gender, smoking and APOE genotypes.
Fiegenbaum M; de Andrade FM; Hutz MH
Clin Chim Acta; 2007 May; 380(1-2):175-81. PubMed ID: 17367769
[TBL] [Abstract][Full Text] [Related]
35. The expression of type III hyperlipoproteinemia: involvement of lipolysis genes.
Henneman P; van der Sman-de Beer F; Moghaddam PH; Huijts P; Stalenhoef AF; Kastelein JJ; van Duijn CM; Havekes LM; Frants RR; van Dijk KW; Smelt AH
Eur J Hum Genet; 2009 May; 17(5):620-8. PubMed ID: 19034316
[TBL] [Abstract][Full Text] [Related]
36. Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans.
Chandak GR; Ward KJ; Yajnik CS; Pandit AN; Bavdekar A; Joglekar CV; Fall CH; Mohankrishna P; Wilkin TJ; Metcalf BS; Weedon MN; Frayling TM; Hattersley AT
BMC Med Genet; 2006 Oct; 7():76. PubMed ID: 17032446
[TBL] [Abstract][Full Text] [Related]
37. Interaction between APOA5 -1131T>C and APOE polymorphisms and their association with severe hypertriglyceridemia.
Sousa MO; Alía P; Pintó X; Corbella E; Navarro MA
Clin Chim Acta; 2008 Sep; 395(1-2):68-71. PubMed ID: 18549811
[TBL] [Abstract][Full Text] [Related]
38. APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome.
Miller M; Rhyne J; Chen H; Beach V; Ericson R; Luthra K; Dwivedi M; Misra A
Arch Med Res; 2007 May; 38(4):444-51. PubMed ID: 17416293
[TBL] [Abstract][Full Text] [Related]
39. SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population.
Wright WT; Young IS; Nicholls DP; Patterson C; Lyttle K; Graham CA
Atherosclerosis; 2006 Apr; 185(2):353-60. PubMed ID: 16125709
[TBL] [Abstract][Full Text] [Related]
40. Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome.
Hiramatsu M; Oguri M; Kato K; Horibe H; Fujimaki T; Watanabe S; Satoh K; Aoyagi Y; Tanaka M; Shin DJ; Lee JH; Jang Y; Yamada Y
Int J Mol Med; 2012 Jul; 30(1):185-92. PubMed ID: 22576629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
